Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CMPXCMPX
14 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in COMPASS THERAPEUTICS INC

CITADEL ADVISORS LLC holds 3.6M shares of CMPX (COMPASS THERAPEUTICS INC), worth $7.8M as of 2026-Q2. The position was increased (+395.0% shares). CMPX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$7.8M

Current Shares

3.6M

Total Value Change

+$7.7M

Total Shares Change

+3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.6M
+395.0%
$7.8M0.0%$2.19
44
2026-Q1
Increased
721,410
+582.6%
$3.8M0.0%$5.53
43
2025-Q4
Decreased
105,682
-54.7%
$567,5120.0%$5.38
0
2025-Q3
New
233,271
-
$816,4490.0%$3.82
34
2024-Q4
Exited
0
-100.0%
$00.0%$1.48
0
2024-Q3
Decreased
64,226
-76.0%
$118,1760.0%$1.88
0
2024-Q2
Increased
267,772
+85.7%
$267,7720.0%$1.00
36
2024-Q1
Decreased
144,185
-13.2%
$285,4860.0%$1.98
0
2023-Q4
New
166,137
-
$259,1740.0%$1.56
32
2023-Q2
Exited
0
-100.0%
$00.0%$2.98
0
2023-Q1
Decreased
44,460
-28.6%
$145,3840.0%$3.19
0
2022-Q4
New
62,276
-
$313,2480.0%$5.03
32
2022-Q1
Exited
0
-100.0%
$00.0%$1.33
0
2021-Q4
New
33,573
-
$106,0000.0%$3.00
33

Other major holders of CMPX: BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used